CLINDOXYL GEL 1 %
CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) : 1 % BENZOYL PEROXIDE : 5 % · DIN 02243158 · GLAXOSMITHKLINE INC
Health Canada status: CANCELLED POST MARKET
What is CLINDOXYL GEL?
CLINDOXYL GEL 1 % contains CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) : 1 % BENZOYL PEROXIDE : 5 %. It is listed in the Health Canada Drug Product Database under DIN 02243158, held by GLAXOSMITHKLINE INC, supplied as GEL for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Nov-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02243158 |
|---|---|
| Brand name | CLINDOXYL GEL |
| Generic / active ingredient | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) : 1 % BENZOYL PEROXIDE : 5 % |
| Manufacturer | GLAXOSMITHKLINE INC |
| Strength | 1 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D10AF51 CLINDAMYCIN, COMBINATIONS |
| AHFS class | 84:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Nov-2025 |
| Original market date | 2001-09-04 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D10AF51 CLINDAMYCIN, COMBINATIONS. 6 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENZACLIN | 5 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02248472 |
| BIACNA TOPICAL GEL | 0.025 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02359685 |
| CABTREO | 3.1 % | Gel | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02550423 |
| CLINDOXYL ADV GEL | 3 % | GEL | GLAXOSMITHKLINE INC | MARKETED | DIN 02382822 |
| TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT | 5 % | GEL | TARO PHARMACEUTICALS INC | MARKETED | DIN 02464519 |
| TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL | 5 % | GEL | TARO PHARMACEUTICALS INC | MARKETED | DIN 02440180 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.